サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1347587

がんワクチン市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
がんワクチン市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のがんワクチン市場規模は2022年に61億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて11.61%の成長率（CAGR）を示し、2028年には121億米ドルに達すると予測しています。

がんは、体内の異常細胞の制御不能な増殖によって引き起こされる悪性腫瘍です。様々な薬やワクチンの使用によって治療することができます。このうちワクチンは、予防用と治療用に大別されます。予防用がんワクチンは、オンコウイルスによって引き起こされるがんを排除し、ヒトパピローマウイルス（HPV）から保護するために使用され、一方、治療用ワクチンは、腫瘍抗原を使用することで、個々の適応免疫系を刺激するのに役立ちます。現在、がんワクチンは抗原型、樹状細胞型、抗イディオタイプなど様々なタイプで市販されています。

がんワクチンの市場動向：

がんの有病率の増加、特にタバコをベースとした製品の消費の増加やライフスタイルの進化が、現在がんワクチン市場の成長を牽引しています。これに伴い、新規がんワクチンの導入に向けた各国の政府機関の積極的な取り組みや、ウイルス組換え型がんワクチン分野での大規模な資金提供が、ヘルスケア分野でのワクチン普及を促進しています。これに伴い、米国食品医薬品局（FDA）が承認したヒトパピローマウイルスワクチン（HPV）やB型肝炎ワクチン（HBV）などのワクチンが、肝臓がんなどの特定の種類のがんのリスクを低減するために広く利用されていることも、市場の成長に寄与しています。また、効果的で特異的ながん治療法の開発に焦点を当てた急速な技術進歩も市場を大きく牽引しています。その他、ヘルスケアインフラの改善、がんを含む様々な慢性疾患に罹患しやすい老年人口の増加、症状や利用可能な治療オプションに関する消費者の意識の高まりなどの要因が、世界中で市場のさらなる明るい見通しを生み出しています。

本レポートで扱う主な質問

  • 世界のがんワクチン市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のがんワクチン市場に与えた影響は？
  • 主要な地域市場は？
  • タイプ別の市場内訳は？
  • 技術別の市場内訳は？
  • 適応症別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界のがんワクチン市場の構造と主要プレーヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 がんワクチンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 予防用がんワクチン
    • 市場動向
    • 市場予測
  • 治療用がんワクチン
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • 樹状細胞がんワクチン
    • 市場動向
    • 市場予測
  • 組み換えがんワクチン
    • 市場動向
    • 市場予測
  • 抗原/アジュバントがんワクチン
    • 市場動向
    • 市場予測
  • ウイルスベクター/DNAがんワクチン
    • 市場動向
    • 市場予測
  • 全細胞がんワクチン
    • 市場動向
    • 市場予測

第8章 市場内訳：適応症別

  • 子宮頸がん
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 小児
    • 市場動向
    • 市場予測
  • 成人
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Anixa Biosciences Inc.
    • Dendreon Pharmaceuticals LLC
    • Dynavax Technologies Corporation
    • GSK plc
    • Merck & Co. Inc.
    • Moderna Inc.
    • OSE Immunotherapeutics
    • Providence Therapeutics
    • Sanofi S.A.
    • UbiVac Inc.
    • Vaccitech plc
図表

List of Figures

  • Figure 1: Global: Cancer Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Vaccines Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cancer Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Cancer Vaccines Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Cancer Vaccines Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Cancer Vaccines Market: Breakup by Indication (in %), 2022
  • Figure 7: Global: Cancer Vaccines Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Cancer Vaccines Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Cancer Vaccines (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Cancer Vaccines (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Cancer Vaccines (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Cancer Vaccines (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Cancer Vaccines (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Cancer Vaccines (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Cancer Vaccines (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Cancer Vaccines (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Cancer Vaccines (Adults) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Cancer Vaccines (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Cancer Vaccines Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: Cancer Vaccines Industry: SWOT Analysis
  • Figure 83: Global: Cancer Vaccines Industry: Value Chain Analysis
  • Figure 84: Global: Cancer Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Vaccines Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cancer Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Cancer Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Cancer Vaccines Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 5: Global: Cancer Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Cancer Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Cancer Vaccines Market: Competitive Structure
  • Table 8: Global: Cancer Vaccines Market: Key Players
目次
Product Code: SR112023A5901

Market Overview:

The global cancer vaccines market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028.

Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated through the use of various medications and vaccines. Between these, vaccines are broadly categorized into preventive and therapeutic. Preventive cancer vaccines are deployed for eliminating cancer caused by oncovirus and protecting from human papillomavirus (HPV), whereas therapeutic vaccines aid in stimulating the individual adaptive immune systems by using tumor antigens. At present, cancer vaccines are commercially available in varying types, such as antigen, dendritic cell, and anti-idiotype.

Cancer Vaccines Market Trends:

The increasing prevalence of cancer, especially due to the rising consumption of tobacco-based products and evolving lifestyles is currently driving the cancer vaccines market growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel cancer vaccines, along with extensive fundings in the field of viral recombinant cancer vaccines are further facilitating the widespread adoption of these vaccines in the healthcare sector. In line with this, the extensive utilization of United States Food and Drug Administration (US FDA) approved vaccines, including human papillomavirus vaccine (HPV) and hepatitis B vaccine (HBV) to reduce the risk of certain types of cancer, such as liver cancer, is contributing to the market growth. The market is also significantly driven by rapid technological advancements focusing on the development of effective and specific cancer treatments. Other factors, such as improving healthcare infrastructure, rising geriatric population, who are susceptible to various chronic ailments, including cancer, and growing consumer awareness regarding the symptoms and the available treatment options, are creating a positive outlook for the market further across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, indication and end user.

Breakup by Type:

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

Breakup by Technology:

Dendritic Cells Cancer Vaccines

Recombinant Cancer Vaccines

Antigen/Adjuvant Cancer Vaccines

Viral Vector and DNA Cancer Vaccines

Whole-cell Cancer Vaccines

Breakup by Indication:

Cervical Cancer

Prostate Cancer

Others

Breakup by End User:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.

Key Questions Answered in This Report:

  • How has the global cancer vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Preventive Cancer Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Therapeutic Cancer Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Dendritic Cells Cancer Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Recombinant Cancer Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Antigen/Adjuvant Cancer Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Viral Vector and DNA Cancer Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Whole-cell Cancer Vaccines
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cervical Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prostate Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pediatrics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adults
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Anixa Biosciences Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Dendreon Pharmaceuticals LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dynavax Technologies Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 GSK plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Merck & Co. Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Moderna Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 OSE Immunotherapeutics
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Providence Therapeutics
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Sanofi S.A.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 UbiVac Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Vaccitech plc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials